This is a West Virginia news story, published by Shelley Capito, that relates primarily to Shelley Moore Capito news.
For more West Virginia news, you can click here:
more West Virginia newsFor more Shelley Moore Capito news, you can click here:
more Shelley Moore Capito newsFor more disease research news, you can click here:
more disease research newsFor more news from Shelley Capito, you can click here:
more news from Shelley CapitoOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
Parkinson. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest legislation efforts news, National Plan news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
highest ParkinsonShelley Capito
•81% Informative
West Virginia Senator Shelley Moore Capito helped introduce a bill tackling Parkinson’s disease back in 2022 .
The bill was signed into law by President Joe Biden on Tuesday .
Around 7,000 people in West Virginia live with Parkinson's disease out of an estimated 1.2 million in the U.S. The state is considered to have the third -highest rate in the nation.
VR Score
81
Informative language
79
Neutral language
78
Article tone
formal
Language
English
Language complexity
67
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links